Total genome polymorphism and low frequency of intra-genomic variation in the uspA1 and uspA2 genes of Moraxella catarrhalis in otitis prone and non-prone children up to 2 years of age - Consequences for vaccine design?

By Hays J.P.   van der Schee C.   Loogman A.   Eadie K.   Verduin C.   Faden H.   Verbrugh H.   van Belkum A.  

Vaccine, Vol. 21, Iss. 11, 2003-03 ,pp. : 1118-1124

Elsevier

Access to resources Recommend Favorite

Evaluation of a 74-kDa transferrin-binding protein from Moraxella (Branhamella) catarrhalis as a vaccine candidate

By Chen D.   McMichael J.C.   VanDerMeid K.R.   Masi A.W.   Bortell E.   Caplan J.D.   Chakravarti D.N.   Barniak V.L.  

Vaccine, Vol. 18, Iss. 1, 1999-08 ,pp. : 109-118

Elsevier

Access to resources Recommend Favorite

An aerosol challenge mouse model for Moraxella catarrhalis

By Hu W.-G.W.-G.   Chen J.   Collins F.M.   Gu X.-X.X.-X.  

Vaccine, Vol. 18, Iss. 9, 1999-12 ,pp. : 799-804

Elsevier

Access to resources Recommend Favorite

Immunogenicity and reactogenicity in UK infants of a novel meningococcal vesicle vaccine containing multiple class 1 (PorA) outer membrane proteins

By Cartwright K.   Morris R.   Rumke H.   Fox A.   Ray Borrow   Begg N.   Richmond P.   Poolman J.  

Vaccine, Vol. 17, Iss. 20, 1999-06 ,pp. : 2612-2619

Elsevier

Access to resources Recommend Favorite

Investigation of mucosal immunisation in pulmonary clearance of Moraxella (Branhamella) catarrhalis

By Kyd J.   John A.   Cripps A.   Murphy T.F.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 398-406

Elsevier

Access to resources Recommend Favorite